US THROMBOTIC MICROANGIOPATHY
Data sourced from IRS 990 public filings
US THROMBOTIC MICROANGIOPATHY TO IMPROVE OUTCOMES FOR PATIENTS WITH THROMBOTIC MICROANGIOPATHY THROUGH COLLABORATION AND ADVOCACY
US THROMBOTIC MICROANGIOPATHY has received 1 grants from 1 known foundation funders. Revenue decreased from $1,860,040 in 2023 to $595,494 in 2024. Most recent reported revenue: $595,494.
Annual Revenue
$595,494
Known Funders
1
Grants Received
1
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $595,494 | $789,565 | $1,823,162 |
| 2023 | $1,860,040 | $669,026 | $2,053,500 |
| 2022 | $950,114 | $300,712 | $797,343 |
Top Funders
SEATTLE, WA
Key Personnel
From 2024 IRS 990 filing
SPERO CATALAND
MEDICAL DIRE
SATHEESH CHONAT
MEDICAL DIRE
ARA METJIAN
MEDICAL DIRE
CLARE MARTIN
OPERATIONS D
SHRUTI CHATURVEDI
MEDICAL DIRE
MARSHALL MAZEPA
MEDICAL DIRE
Frequently Asked Questions
Other Nonprofits in Ohio
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.